InvestorsHub Logo
Followers 5
Posts 1278
Boards Moderated 0
Alias Born 04/15/2019

Re: humpback post# 1538

Monday, 12/19/2022 11:33:30 AM

Monday, December 19, 2022 11:33:30 AM

Post# of 1673
The day Moderna got emergency use approval for their covid vaccine, their stock price was at $18 per share. Twenty months later, it was at $449 per share.

I would not be shocked to see a similar trajectory or better.

If you were referring about how high the stock could go that day on receiving positive news, I'd use Madrigal Pharmaceuticals (MDGL) as an example. They just got positive news for their phase 3 Nash trials on Friday night. Their stock more than tripled from $63.60 to $207.80 on Monday.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ORMP News